DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Rucaparib camsylateis the generic ingredient in one branded drug marketed by Clovis Oncology Inc and is included in one NDA. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Rucaparib camsylate has two hundred and seventy-six patent family members in fifty-three countries.
One supplier is listed for this compound.
Recent Clinical Trials for rucaparib camsylate
Identify potential brand extensions & 505(b)(2) entrants
|National Cancer Institute (NCI)||Phase 3|
|Alliance for Clinical Trials in Oncology||Phase 3|
|Clovis Oncology, Inc.||Phase 2|
Pharmacology for rucaparib camsylate
|Drug Class||Poly(ADP-Ribose) Polymerase Inhibitor |
|Mechanism of Action||Poly(ADP-Ribose) Polymerase Inhibitors |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Clovis Oncology Inc||RUBRACA||rucaparib camsylate||TABLET;ORAL||209115-001||Dec 19, 2016||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|Clovis Oncology Inc||RUBRACA||rucaparib camsylate||TABLET;ORAL||209115-002||Dec 19, 2016||RX||Yes||Yes||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|Clovis Oncology Inc||RUBRACA||rucaparib camsylate||TABLET;ORAL||209115-003||May 1, 2017||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2534153||2018C/044||Belgium||⤷ Free Forever Trial||PRODUCT NAME: RUCAPARIB-CAMSYLAAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1250 20180529|
|2534153||2018/043||Ireland||⤷ Free Forever Trial||PRODUCT NAME: RUCAPARIB CAMSYLATE; REGISTRATION NO/DATE: EU/1/17/1250 20180524|
|2534153||PA2018517,C2534153||Lithuania||⤷ Free Forever Trial||PRODUCT NAME: RUKAPARIBO KAMSILATAS; REGISTRATION NO/DATE: EU/1/17/1250 20180524|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.